Establishment Labs Holdings (ESTA) Operating Income (QoQ) (2017 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Establishment Labs Holdings | 2.04 Bn | 1.97 Bn | 42.34 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -65.67% |
| Dec 31, 2025 | 2.36% |
| Sep 30, 2025 | 71.47% |
| Jun 30, 2025 | 16.75% |
| Mar 31, 2025 | 9.23% |
| Dec 31, 2024 | -42.10% |
| Sep 30, 2024 | -40.61% |
| Jun 30, 2024 | -5.77% |
| Mar 31, 2024 | 60.05% |
| Dec 31, 2023 | -5.12% |
| Sep 30, 2023 | -53.42% |
| Jun 30, 2023 | -68.05% |
| Mar 31, 2023 | 37.99% |
| Dec 31, 2022 | -25.13% |
| Sep 30, 2022 | -1.07% |
| Jun 30, 2022 | -86.65% |
| Mar 31, 2022 | 40.48% |
| Dec 31, 2021 | -3.56% |
| Sep 30, 2021 | -95.17% |
| Jun 30, 2021 | -121.09% |
| Mar 31, 2021 | 73.86% |
| Dec 31, 2020 | -209.42% |
| Sep 30, 2020 | 73.02% |
| Jun 30, 2020 | -24.63% |
| Mar 31, 2020 | -74.91% |
| Dec 31, 2019 | 49.74% |
| Sep 30, 2019 | 6.59% |
| Jun 30, 2019 | -11.86% |
| Mar 31, 2019 | 2.70% |
| Dec 31, 2018 | -42.59% |
| Sep 30, 2018 | 4.29% |
| Jun 30, 2018 | -119.34% |
| Mar 31, 2018 | 37.23% |
| Dec 31, 2017 | 23.16% |
| Sep 30, 2017 | -8.92% |